Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 30;23(19):11554.
doi: 10.3390/ijms231911554.

Chromone-Containing Allylmorpholines Influence Ion Channels in Lipid Membranes via Dipole Potential and Packing Stress

Affiliations

Chromone-Containing Allylmorpholines Influence Ion Channels in Lipid Membranes via Dipole Potential and Packing Stress

Svetlana S Efimova et al. Int J Mol Sci. .

Abstract

Herein, we report that chromone-containing allylmorpholines can affect ion channels formed by pore-forming antibiotics in model lipid membranes, which correlates with their ability to influence membrane boundary potential and lipid-packing stress. At 100 µg/mL, allylmorpholines 1, 6, 7, and 8 decrease the boundary potential of the bilayers composed of palmitoyloleoylphosphocholine (POPC) by about 100 mV. At the same time, the compounds do not affect the zeta-potential of POPC liposomes, but reduce the membrane dipole potential by 80-120 mV. The allylmorpholine-induced drop in the dipole potential produce 10-30% enhancement in the conductance of gramicidin A channels. Chromone-containing allylmorpholines also affect the thermotropic behavior of dipalmytoylphosphocholine (DPPC), abolishing the pretransition, lowering melting cooperativity, and turning the main phase transition peak into a multicomponent profile. Compounds 4, 6, 7, and 8 are able to decrease DPPC's melting temperature by about 0.5-1.9 °C. Moreover, derivative 7 is shown to increase the temperature of transition of palmitoyloleoylphosphoethanolamine from lamellar to inverted hexagonal phase. The effects on lipid-phase transitions are attributed to the changes in the spontaneous curvature stress. Alterations in lipid packing induced by allylmorpholines are believed to potentiate the pore-forming ability of amphotericin B and gramicidin A by several times.

Keywords: allylmorpholine; chromone; ion channel; membrane.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
The relationships between the structures of allylmorpholines and their potential-modifying abilities: the dependence of dipole modifying efficiency of allylmorpholines on (A) the length of hydrophobic chain in R5 position; (B) lengths of hydrocarbon radicals in R4 and R5 positions; (C) the type of halogen in the R1 position; (D) the existence of halogen in R1 and R3 positions.
Figure 2
Figure 2
(A) Current fluctuations corresponding to opening and closing single gramicidin A channels in the absence (control) and presence of 5 and 7 at 100 μg/mL. V = 150 mV. C—closed state of the channel, O—open state of the channel. (B) gsc(V) curves of single gramicidin A channels in the absence and presence of chromone-containing allylmorpholines at 100 μg/mL. The relationship between the color of the symbol and the compound is given in the figure legend. (C) The effects of 5 and 7 on pore-forming activity of gramicidin A. A peptide was added into the bathing solution at both sides of the bilayers up to 1 nM. The moments when up to 100 μg/mL of 5 (upper panel) and 7 (lower panel) was added in the bilayer bathing solution are indicated by arrows. The membranes were composed of POPC and bathed in 2.0 M KCl (pH 7.4). V = 150 mV.
Figure 3
Figure 3
The schematic representations of the mechanisms of the action of allylmorpholine 7 on the conductance of GrA channels via alterations in membrane dipole potential.
Figure 4
Figure 4
Heating thermograms of DPPC liposomes in the absence and presence of various chromone-containing allylmorpholine derivatives at 100 μg/mL. (A) control, 1, 2, 3, 4, 5, and 6; (B) 7, 8, 9, 10, 11, and 12. The relationship between the profile and the compound is given in the figure.
Figure 5
Figure 5
The effects of chromone-containing allylmorpholines (4, 6, 7, 8) on the steady-state transmembrane current flowing through membranes modified by one-sided addition of AmB. The moments when 100 μg/mL of 4 (A), 6 (B), 7 (C), and 8 (D) was added to the bilayer bathing solution are indicated by arrows. The lipid bilayers were composed of POPC/CHOL (80/20 mol%) and were bathed in 2.0 M 4KCl, pH 7.4. V = 50 mV.
Figure 6
Figure 6
The schematic representations of the mechanisms of action of allylmorpholine 7 on the pore-forming activity of AmB via alterations in lipid-packing stress.

Similar articles

Cited by

References

    1. Hughes R.E., Nikolic K., Ramsay R.R. One for all hitting multiple Alzheimer’s disease targets with one drug. Front. Neurosci. 2016;10:177. doi: 10.3389/fnins.2016.00177. - DOI - PMC - PubMed
    1. Manera C., Martinelli A., Nencetti S., Romagnoli F., Rossello A., Giannaccini G., Scatizzi R., Cozzini P., Domiano P. X-ray analysis, theoretical studies and aadrenergic biopharmacological properties of 1-(2,5 dimethoxyphenyl)-2- aminoethanol and its morpholine analogue. Eur. J. Med. Chem. 1994;29:519–525. doi: 10.1016/0223-5234(94)90144-9. - DOI
    1. Repsold B.P., Malan S.F., Joubert J., Oliver D.W. Multi-targeted directed ligands for Alzheimer’s disease: Design of novel lead coumarin conjugates. SAR QSAR Environ. Res. 2018;29:231–255. doi: 10.1080/1062936X.2018.1423641. - DOI - PubMed
    1. Bertron J.L., Cho H.P., Garcia-Barrantes P.M., Panarese J.D., Salovich J.M., Nance K.D., Engers D.W., Rook J.M., Blobaum A.L., Niswender C.M., et al. The discovery of VU0486846: Steep SAR from a series of M1 PAMs based on a novel benzomorpholine core. Bioorg. Med. Chem. Lett. 2018;28:2175–2179. doi: 10.1016/j.bmcl.2018.05.009. - DOI - PMC - PubMed
    1. Rook J.M., Bertron J.L., Cho H.P., Garcia-Barrantes P.M., Moran S.P., Maksymetz J.T., Nance K.D., Dickerson J.W., Remke D.H., Chang S., et al. A novel M1 PAM VU0486846 exerts efficacy in cognition models without displaying agonist activity or cholinergic toxicity. ACS Chem. Neurosci. 2018;9:2274–2285. doi: 10.1021/acschemneuro.8b00131. - DOI - PMC - PubMed

LinkOut - more resources